Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7509973 [patent_doc_number] => 20110256139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Therapeutic Uses Of Monoclonal Antibodies To The Angiotensin-II Type 1 Receptor' [patent_app_type] => utility [patent_app_number] => 13/087770 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5474 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256139.pdf [firstpage_image] =>[orig_patent_app_number] => 13087770 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/087770
Therapeutic uses of monoclonal antibodies to the angiotensin-II type 1 receptor Apr 14, 2011 Issued
Array ( [id] => 8963479 [patent_doc_number] => 20130203081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'TUMOR CELL-DERIVED MICROVESICLES' [patent_app_type] => utility [patent_app_number] => 13/641085 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16138 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641085 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/641085
TUMOR CELL-DERIVED MICROVESICLES Apr 12, 2011 Abandoned
Array ( [id] => 9889119 [patent_doc_number] => 08975375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-10 [patent_title] => 'Identification of tumor-associated antigens for diagnosis and therapy' [patent_app_type] => utility [patent_app_number] => 13/086176 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 40 [patent_no_of_words] => 23542 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13086176 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/086176
Identification of tumor-associated antigens for diagnosis and therapy Apr 12, 2011 Issued
Array ( [id] => 7777223 [patent_doc_number] => 20120040356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'Methods for Detecting Oncofetal Fibronectin' [patent_app_type] => utility [patent_app_number] => 13/081826 [patent_app_country] => US [patent_app_date] => 2011-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 165191 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040356.pdf [firstpage_image] =>[orig_patent_app_number] => 13081826 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/081826
Methods for detecting oncofetal fibronectin Apr 6, 2011 Issued
Array ( [id] => 8708639 [patent_doc_number] => 20130065928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'BIOMARKERS FOR PI3K-DRIVEN CANCER' [patent_app_type] => utility [patent_app_number] => 13/638925 [patent_app_country] => US [patent_app_date] => 2011-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7564 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13638925 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/638925
BIOMARKERS FOR PI3K-DRIVEN CANCER Apr 1, 2011 Abandoned
Array ( [id] => 6046729 [patent_doc_number] => 20110206691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'Methods and Compositions for Treating Neuroblastoma' [patent_app_type] => utility [patent_app_number] => 13/072090 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 27606 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206691.pdf [firstpage_image] =>[orig_patent_app_number] => 13072090 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/072090
Methods and Compositions for Treating Neuroblastoma Mar 24, 2011 Abandoned
Array ( [id] => 9299603 [patent_doc_number] => 08647826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-11 [patent_title] => 'Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer' [patent_app_type] => utility [patent_app_number] => 13/052002 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 49 [patent_no_of_words] => 114057 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13052002 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/052002
Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer Mar 17, 2011 Issued
Array ( [id] => 8637554 [patent_doc_number] => 20130029357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'DIAGNOSTIC MARKER FOR EFFECT OF ANTICANCER AGENT' [patent_app_type] => utility [patent_app_number] => 13/635911 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6072 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635911 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/635911
Diagnostic marker for effect of anticancer agent Mar 17, 2011 Issued
Array ( [id] => 6174422 [patent_doc_number] => 20110177103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR' [patent_app_type] => utility [patent_app_number] => 13/045722 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 79603 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177103.pdf [firstpage_image] =>[orig_patent_app_number] => 13045722 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/045722
Compositions and methods for the diagnosis and treatment of tumor Mar 10, 2011 Issued
Array ( [id] => 6101656 [patent_doc_number] => 20110165148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 162P1E6 USEFUL IN TREATMENT AND DETECTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/043221 [patent_app_country] => US [patent_app_date] => 2011-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 87 [patent_no_of_words] => 72174 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165148.pdf [firstpage_image] =>[orig_patent_app_number] => 13043221 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/043221
Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer Mar 7, 2011 Issued
Array ( [id] => 6101693 [patent_doc_number] => 20110165185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'IMMUNOGENIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/038794 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21583 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165185.pdf [firstpage_image] =>[orig_patent_app_number] => 13038794 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/038794
Immunogenic peptides Mar 1, 2011 Issued
Array ( [id] => 9922613 [patent_doc_number] => 08980570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-17 [patent_title] => 'Composition for cancer prognosis prediction comprising anti-TMAP/CKAP2 antibodies' [patent_app_type] => utility [patent_app_number] => 13/577126 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14011 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577126 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/577126
Composition for cancer prognosis prediction comprising anti-TMAP/CKAP2 antibodies Jan 31, 2011 Issued
Array ( [id] => 9523575 [patent_doc_number] => 08747833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'B7-H1 and methods of diagnosis, prognosis, and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 13/012063 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12779 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13012063 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/012063
B7-H1 and methods of diagnosis, prognosis, and treatment of cancer Jan 23, 2011 Issued
Array ( [id] => 6001702 [patent_doc_number] => 20110117572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Antibody Specific to the AIMP2-DX2' [patent_app_type] => utility [patent_app_number] => 13/011386 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 21715 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117572.pdf [firstpage_image] =>[orig_patent_app_number] => 13011386 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/011386
Antibody Specific to the AIMP2-DX2 Jan 20, 2011 Abandoned
Array ( [id] => 8585603 [patent_doc_number] => 20130004424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'METHODS FOR DETERMINING AGENTS TARGETING MENA ISOFORMS AND USES THEREOF FOR DIAGNOSIS AND TREATMENT OF METASTATIC TUMORS' [patent_app_type] => utility [patent_app_number] => 13/575359 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5548 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575359 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/575359
METHODS FOR DETERMINING AGENTS TARGETING MENA ISOFORMS AND USES THEREOF FOR DIAGNOSIS AND TREATMENT OF METASTATIC TUMORS Jan 18, 2011 Abandoned
Array ( [id] => 8909413 [patent_doc_number] => 08481477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors' [patent_app_type] => utility [patent_app_number] => 12/930592 [patent_app_country] => US [patent_app_date] => 2011-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 44 [patent_no_of_words] => 28988 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12930592 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/930592
Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors Jan 10, 2011 Issued
Array ( [id] => 6083669 [patent_doc_number] => 20110144034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'INHIBITION OF TUMOR METASTASES USING PROTEIN KINASE C (PKC) INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/976873 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 11014 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144034.pdf [firstpage_image] =>[orig_patent_app_number] => 12976873 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/976873
INHIBITION OF TUMOR METASTASES USING PROTEIN KINASE C (PKC) INHIBITORS Dec 21, 2010 Abandoned
Array ( [id] => 6102602 [patent_doc_number] => 20110166095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'CANCER PLATINUM RESISTANCE DETECTION AND SENSITIZATION METHOD' [patent_app_type] => utility [patent_app_number] => 12/975970 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7413 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166095.pdf [firstpage_image] =>[orig_patent_app_number] => 12975970 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/975970
Cancer platinum resistance detection and sensitization method Dec 21, 2010 Issued
Array ( [id] => 5977520 [patent_doc_number] => 20110154522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'BH3 Peptides And Method Of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/966821 [patent_app_country] => US [patent_app_date] => 2010-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21574 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20110154522.pdf [firstpage_image] =>[orig_patent_app_number] => 12966821 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/966821
BH3 peptides and method of use thereof Dec 12, 2010 Issued
Array ( [id] => 8054077 [patent_doc_number] => 20120076775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Combination of HGF Inhibitor and EGF Inhibitor to Treat Cancer' [patent_app_type] => utility [patent_app_number] => 12/963595 [patent_app_country] => US [patent_app_date] => 2010-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10186 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076775.pdf [firstpage_image] =>[orig_patent_app_number] => 12963595 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/963595
Combination of HGF Inhibitor and EGF Inhibitor to Treat Cancer Dec 7, 2010 Abandoned
Menu